
Breakout Labs
Description
Breakout Labs, an initiative of the Thiel Foundation, stands as a distinctive early-stage funder based in San Francisco, United States. Launched in 2011, its core mission is to bridge the critical gap between groundbreaking scientific research and commercial viability, supporting companies that are often deemed too nascent or high-risk for traditional venture capital. Unlike conventional investors, Breakout Labs provides non-dilutive funding, meaning they do not take equity in the companies they support, allowing founders to retain full ownership of their intellectual property and ventures. This unique model is particularly attractive to deep tech startups requiring substantial upfront capital for R&D without immediate pressure for commercial returns.
The organization's investment thesis centers on high-impact scientific and technological breakthroughs across a diverse range of sectors. Their portfolio spans areas such as food science, biomedicine, clean energy, advanced materials, robotics, and artificial intelligence. Breakout Labs seeks out projects with significant scientific hurdles but also immense potential to revolutionize industries or solve pressing global challenges. They act as a crucial catalyst, providing not only financial backing but also access to a robust network of scientific advisors, mentors, and resources to help these nascent companies navigate the complex journey from lab to market.
Since its inception, Breakout Labs has played a pivotal role in nurturing a new generation of scientific enterprises. They typically provide up to $350,000 in initial non-dilutive funding to their portfolio companies, a substantial sum designed to enable critical early-stage experimentation and development. As of 2017, Breakout Labs had supported over 50 companies, collectively disbursing more than $15 million to accelerate the development of innovative technologies. This consistent support underscores their commitment to fostering radical scientific innovation and transforming ambitious research into tangible, impactful products and services.
Investor Profile
Breakout Labs has backed more than 38 startups, with 0 new investments in the last 12 months alone. The firm has led 13 rounds, about 34% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Grant, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Manufacturing.
- Typical check size: $100K – $350K.
Stage Focus
- Seed (58%)
- Grant (29%)
- Series Unknown (5%)
- Private Equity (3%)
- Pre Seed (3%)
- Series A (3%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Manufacturing
- Therapeutics
- Chemical
- Medical
- Medical Device
- Beauty
- Sensor
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.